Researchers have found genes in mice that help cells survive exposure to cytokines during sepsis.
Sepsis occurs when the body’s immune response to infection spirals out of control. Bacteria in the bloodstream trigger immune cells to release cytokines to quickly activate the body’s defenses. Sometimes the response goes overboard, creating a so-called “cytokine storm” that leaves people feverish or chilled, disoriented, and in pain. In severe cases, it can lead to multi-organ failure and death.
The newly discovered genes are involved in disposing cellular waste, a process known as autophagy. Mice that lack key autophagy genes are more likely to die from sepsis, the study shows.
The findings raise the possibility that enhancing autophagy could potentially lead to treatments for the deadly condition.
Understanding sepsis survival
“When we recognize signs of sepsis in patients, we prescribe antibiotics and fluids, but we lack therapies to protect patients from the direct effects of the cytokine storm,” says first author Anthony Orvedahl, an instructor in pediatric infectious diseases at Washington University School of Medicine in St. Louis.
“Our research indicates that if we could modulate autophagy levels in cells, we might be able to promote cell survival and resistance to the cytokine storm, which may ultimately help people survive sepsis.”
Sepsis is a medical emergency, and even with prompt medical care, about 15 percent of people do not survive, while many survivors experience longstanding complications. Orvedahl and colleagues set out to find what protects cells from dying during a cytokine storm.
The researchers looked at the effects of interferon gamma, a cytokine that activates immune cells’ ability to kill bacteria but can also trigger cell death. By systematically inactivating one gene at a time from immune cells in a dish before treating them with interferon gamma, the researchers discovered that cells need a full complement of autophagy genes to survive exposure to the potent cytokine.
Further experiments revealed that a second cytokine, called tumor necrosis factor, was also critical for the accelerated cell death in this system.
Cleaning house
“Autophagy is like cleaning the house, getting rid of all the junk inside the cell,” Orvedahl says. “If unwanted things start to accumulate via a defect in this recycling system, it’s like a tinderbox waiting for a spark. We don’t yet know the exact material involved, but we think something builds up and makes cells more vulnerable to dying when they encounter these inflammatory cytokines.”
The importance of autophagy on cell survival suggests that the process may also be crucial for the survival of animals—and people—in the midst of a cytokine storm. To find out, the researchers studied four strains of genetically modified mice that lacked one of four autophagy genes in their immune cells, as well as mice with intact autophagy genes. They injected mice with tumor necrosis factor, which scientists think drives the cytokine storm in people. The mice whose autophagy systems were crippled by the absence of important autophagy genes got sick faster and were more likely to die.
Researchers focused on cancer, cardiovascular disease, and other conditions are already studying chemical compounds that enhance or block autophagy. Therapies that suppress autophagy may increase the risk of sepsis, Orvedahl says. Further, he cautions that more research is needed before doctors can evaluate whether boosting autophagy is a viable strategy for treating sepsis.
“We can’t say for sure that autophagy activation would be protective,” Orvedahl says. “We just showed that if mice lack autophagy, they are sicker and more likely to die. But we think that a better understanding of these processes could lead to attractive targets for developing more effective ways to treat sepsis.”
The study appears in the Proceedings of the National Academy of Sciences.
Additional researchers from Washington University and Vir Biotechnology contributed to the work. The National Institutes of Health and Pediatric Infectious Diseases Society—St. Jude Children’s Research Hospital Fellowship Program in Basic Research supported the research.
